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Abstract
Primary Ciliary Dyskinesia is a heterogeneous genetic disease that is characterized by cilia dysfunction of the epithelial cells
lining the respiratory tracts, resulting in recurrent respiratory tract infections. Despite lifelong physiological therapy and
antibiotics, the lungs of affected patients are progressively destroyed, leading to respiratory insufficiency. Recessive
mutations in Dynein Axonemal Intermediate chain type 1 (DNAI1) gene have been described in 10% of cases of Primary Ciliary
Dyskinesia. Our goal was to restore normal ciliary beating in DNAI1–deficient human airway epithelial cells. A lentiviral
vector based on Simian Immunodeficiency Virus pseudotyped with Vesicular Stomatitis Virus Glycoprotein was used to
transduce cultured human airway epithelial cells with a cDNA of DNAI1 driven by the Elongation Factor 1 promoter.
Transcription and translation of the transduced gene were tested by RT–PCR and western blot, respectively. Human airway
epithelial cells that were DNAI1–deficient due to compound heterozygous mutations, and consequently had immotile cilia
and no outer dynein arm, were transduced by the lentivirus. Cilia beating was recorded and electron microscopy of the cilia
was performed. Transcription and translation of the transduced DNAI1 gene were detected in human cells treated with the
lentivirus. In addition, immotile cilia recovered a normal beat and outer dynein arms reappeared. We demonstrated that it is
possible to obtain a normalization of ciliary beat frequency of deficient human airway epithelial cells by using a lentivirus to
transduce cells with the therapeutic gene. This preliminary step constitutes a conceptual proof that is indispensable in the
perspective of Primary Ciliary Dyskinesia’s in vivo gene therapy. This is the first time that recovery of cilia beating is
demonstrated in this disease.
Citation: Chhin B, Negre D, Merrot O, Pham J, Tourneur Y, et al. (2009) Ciliary Beating Recovery in Deficient Human Airway Epithelial Cells after Lentivirus Ex Vivo
Gene Therapy. PLoS Genet 5(3): e1000422. doi:10.1371/journal.pgen.1000422
Editor: Nicholas Katsanis, Johns Hopkins University School of Medicine, United States of America
Received December 1, 2008; Accepted February 13, 2009; Published March 20, 2009
Copyright:  2009 Chhin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: BC was supported by a stipend from Association Franc ¸aise contre les Myopathies (AFM) from 2004 to 2007. The Laboratoire Cardioge ´ne ´tique is
supported by grants from GIS-Maladies Rares, 2003 re ´gional PHRC, 2008 national PHRC, Foundation Renaud Febvre, and Carvajal-ProKartagener Foundation.
None of these sponsors participated in the design, the conduct, the analysis or the interpretation of the study, or in the review or approval of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: patrice.bouvagnet@recherche.univ-lyon1.fr
Introduction
Primary Ciliary Dyskinesia (PCD, OMIM #242650) is an
inherited disease mainly characterized by dysfunction of airways’
motile cilia. The prevalence is approximately 1 in 12,000–20,000
[1–3]. About 50% of patients affected by PCD have a situs inversus
which results from monocilia dysfunction at the embryonic node
[4]. This association is referred to as Kartagener’s syndrome
(OMIM #244400) [5]. PCD causes chronic sinus and bronchial
respiratory infections that begin early in life, leading to nasal
polyps and bronchiectasis. Males are frequently sterile due to
dysfunctional spermatozoa flagella [6]. Other symptoms can also
be associated with PCD like hydrocephalus, anosmia, retinitis
pigmentosa and congenital heart diseases [7–10].
The disorder is genetically heterogeneous and in most cases,
inheritance is autosomal recessive but X-linked inheritance
patterns were also described [11]. Several loci and some genes
have been identified, as DNAI1 (Ensembl ENSG00000122735),
DNAH5 (ENSG00000039139), DNAH11 (ENSG00000105877),
RPGR (ENSG00000156313), TXNDC3 (ENSG00000086288),
OFD1 (ENSG00000046651), DNAI2 (ENSG00000171595) and
KTU (alias C14orf104) (OTTHUMG00000152331) genes [10,12–
19]. The first gene described to be responsible for PCD and
Kartagener syndrome was DNAI1 gene [18,20]. Eighteen
mutations in DNAI1 gene were reported, and Zariwala et al.
evidenced a founder effect for the most frequent mutation
(c.48+2_48+3insT) [21]. Moreover, the authors estimated that
mutations in DNAI1 gene represent about 10% of PCD cases.
DNAI1 encodes an axonemal dynein intermediate chain, a
component of the outer dynein arm (ODA). Dyneins are
molecular motors which produce energy for microtubules doublets
sliding in the axoneme. To date, no etiologic treatment of PCD is
available and on the long range, PCD leads to respiratory
insufficiency and lung transplant.
We hypothesized that gene therapy could restore ciliary
function in DNAI1-mutated airway epithelial cells to prevent
patients from infectious complications. To introduce genetic
material into cells we focused on lentiviral gene transfer because
lentivirus has the property to integrate its genetic material into host
cell genome even in non-replicating cell [22]. Moreover, lentivirus
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efficiency was reported to decrease after several administrations in
a clinical study of patients suffering from cystic fibrosis [23].
Lentiviral-derived vectors used in gene therapy were principally
based on SIV (simian immunodeficiency virus) or HIV (human
immunodeficiency virus). For this latter one, gene transfer
efficiency into bronchial epithelium in mice was already
demonstrated [24].
We decided to modify a SIV-based vector, previously described
by Negre et al. to efficiently transduce mature human dendritic
cells [25,26], and to transduce human airway epithelial cells
(HAECs) cultured as described by Jorissen et al. [27]. First, we
showed here that normal HAECs were efficiently transduced by
SIV-based vector containing eGFP gene. Then, we validated
lentiviral vectors’ constructions containing DNAI1 cDNA sequence
and showed that transduced DNAI1 is transcribed and expressed.
Finally, we demonstrated that transduction of DNAI1-mutated
HAECs with wild-type DNAI1 can restore ciliary beating and that
ODA are binding again to microtubules.
Results
Transduction of HAECs with pGFP
To estimate whether HAECs could be transduced by a SIV-
based lentivirus pseudotyped with VSV-G, normal HAECs were
infected with pGFP a vector containing eGFP as a reporter gene in
a variety of conditions [25,26]. Three parameters were investi-
gated: (1) the multiplicity of infection (MOI), (2) the moment of
infection and (3) whether using a polycation, Polybrene, or not.
Two different moments of infection during Jorissen’s culture were
tested: at J+1, cells were ciliated and in suspension or at J+3, cells
were de-differentiated and adherent. Two days post-infection,
reporter gene expression was analyzed by FACS (Figure 1). In any
of the selected conditions, HAECs were transduced but the
proportion of transduced cells seemed to be dependant on MOI
irrespective of the other parameters, and apparently higher at
MOI 75. Then, transduction of cells infected at J+1 seemed more
efficient compared to cells infected at J+3. At MOI 75,
approximately 38% of cells infected at J+1 were transduced versus
20% for cells infected at J+3. Moreover, these results seemed to be
improved by the use of Polybrene. Finally, at MOI 75,
transduction efficiency was quantified at about 38% for cells
infected at J+1 without Polybrene compared to approximately
50% for cells infected at J+1 with the use of Polybrene. These
experiments which were not repeated, demonstrated that HAECs
could be transduced in a variety of conditions and that J+1 with
Polybrene at a MOI of 75 were presumably the best experimental
conditions for HAECs infection. Therefore, we selected these
conditions for further experiments.
DNAI1 cDNA Cloning in Lentiviral Vectors
Full-length DNAI1 cDNA was cloned into the lentiviral vector in
place of eGFP gene. Two constructions were obtained using BamH
I and Xho I restriction sites (pK-DNAI1)o rNco I and Xho I
(pK+DNAI1), and resulted respectively in an intact DNAI1 cDNA
associated with a modified Kozak sequence which could prevent
normal translation, or an intact Kozak sequence associated with a
modified DNAI1 cDNA which could result in a dysfunctional
protein (Figure 2A). Then, to differentiate endogene from exogene
DNAI1, a hemagglutinin tag (HA) was added at the 39 side of
DNAI1 cDNA sequence in each plasmid which resulted in two
additional vectors: pK-HA or pK+HA (Figure 2B).
Detection of DNAI1 Gene Expression in Transduced
Normal HAECs
Normal HAECs were transduced at J+1 with Polybrene at a
MOI of 75 since these conditions gave satisfactory results as
evaluated with eGFP. First, mRNA extracts from transduced
HAECs were controlled by PCR with alpha-tubulin specific primers
for absence of genomic DNA (gDNA) contamination (not shown).
Second,weconfirmedthatnon-ciliatedHAECs(NC)donotexpress
DNAI1 because DNAI1 specific RT primer (P5) led to an absence of
amplification by contrast to re-ciliated HAECs (RC) template
(Figure 3, lanes 1 and 2). Third, DNAI1 mRNA was not amplified
using a HA-tag RT specific primer (HA) from non-infected re-
ciliated HAECs (Figure 3, lane 3). To test DNAI1 transcription from
lentiviral vectors, HA-tagged DNAI1 gene transcriptionwas revealed
by RT-PCR using HA-DNAI1 specific primers. Re-ciliated HAECs
infected by particles containing HA-tagged DNAI1 with either an
exactKozaksequence(pK+HA) ora modified Kozaksequence(pK-
Figure 1. Transduction efficiency analysis by FACS two days
after HAECs infection with pGFP vector. MOI, multiplicity of
infection (3 values of MOI were tested 7, 35, and 75); J+1, one day after
biopsy, ciliated cells in suspension; J+3, three days after biopsy, de-
differentiated and adherent cells; +, with use of Polybrene; 2, without
use of Polybrene. These results were obtained from a single experiment
in each condition. MOI is the ratio of infectious agents (e. g. lentivirus)
to infection targets (e. g. cells).
doi:10.1371/journal.pgen.1000422.g001
Author Summary
This manuscript reports on a successful gene therapy
attempt on human airway epithelial cells of a patient
suffering from Primary Ciliary Dyskinesia. In this autosomal
recessive disease, cilia of the epithelial cells that border the
upper and lower respiratory tracks are not functioning. As
a result, patients suffer from recurrent airway infections
leading progressively to respiratory insufficiency. There is
no treatment as of today that could restore normal ciliary
beating. In this report, we showed that it is feasible to
transfer a therapeutic gene to human airway epithelial
cells with a lentivirus. This transferred gene is transcribed
and expressed. Moreover, defective cells that had immotile
cilia due to compound heterozygous mutations in the
DNAI1 gene recovered ciliary beating after treatment with
a lentivirus containing a normal DNAI1 gene. This is the
first report on gene therapy in Primary Ciliary Dyskinesia.
Since lentivirus is able to insert therapeutic genes into the
cell genome, this result may have impact on in vivo gene
therapy in this disease and in diseases related to human
epithelial airway cells such as cystic fibrosis.
Ciliary Beating Recovery
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Non-ciliated HAECs infected by pK-HA particles also expressed
HA-tagged DNAI1 (Figure 3, lane 6). In conclusion, DNAI1
transcription is efficient from vectors containing a conserved or a
modified Kozak sequence and transcription of the transduced
DNAI1 cDNA driven by Elongation Factor-1 promoter is active in
non-ciliated and re-ciliated HAECs.
Detection of DNAI1 Proteins in Transfected 293Bosc Cells
To detect DNAI1 protein translation from lentiviral vectors,
293Bosc cell line which naturally does not express DNAI1 was
transfected by each lentiviral vector using ExGen500.
DNAI1 protein was detected by Western blot with specific anti-
DNAI1 antibodies after 293Bosc cells’ transfection with the Kozak
modified (pK-DNAI1) or Kozak conserved (pK+DNAI1) DNAI1
sequence (Figure 4, lane 1 and 2). DNAI1 protein was also
detected after 293Bosc cells’ transfection with the vectors
containing HA appended to the 39 end of DNAI1 sequence
(Figure 4, lane 3: modified Kozak and lane 5: conserved Kozak
sequence). By contrast, no DNAI1 protein could be detected by
Western blot in protein lysate of non-transfected 293Bosc cells
with anti-DNAI1 antibodies (Figure 4, lane 4).
Moreover, immunofluorescence assays showed that in pK-HA
transfected 293Bosc cells, cytoplasmic HA-tagged DNAI1 proteins
could be specifically detected by HA antibodies (Figure S1).
Transduction of DNAI1–Mutated HAECs
In the second set of experiments, transduction was performed
on DNAI1-mutated HAEC at J+1 and cells were cultured to
generate ciliated vesicles. DNAI1-mutated HAECs were trans-
duced with pK-DNAI1 or pK-HA to determine if immotile cilia
might recover a beat. The same protocol of transduction was used
as for normal HAECs. We confirmed DNAI1-mutated HAECs
transduction efficiency with pGFP vector, as de-differentiated cells
at J+3 and re-ciliated cells at J’+17 (17 days post-collagen
digestion) expressed GFP protein (Figure S2).
After re-differentiation, GFP transduced HAECs were covered
with cilia (Figure 5A-A) but these cilia were immotile. The
variation of optic signal along a line crossing the cilia during 400
msec does not show any movement (Figure 5A-B). This immotily is
also visible on video recording (Video S1). By contrast, ciliary
beating was recorded on DNAI1-mutated HAECs transduced with
either pK-DNAI1 or pK-HA vector (Figure 5A-C). This beat is
demonstrated by recording the variation of optic signal along a
line crossing cilia. Waves are clearly visible (Figure 5A-D) that
evidenced the periodic beat of cilia. This active beat is also visible
on video recording (Video S2). At J’+30, a ciliary beat frequency
(CBF) was measured for pK-DNAI1 and pK-HA transduced cells.
CBF of HAECs with beating cilia were 9.9561.23 Hz and
11.3160.85 Hz, for pK-DNAI1 and pK-HA treated cells, respec-
tively. These values fall into the range of control HAECs (from 7 to
11 Hz). Cilia length in DNAI1-mutated HAECs was estimated at
6 mm in all cases and did not depend on DNAI1 treatment and
cilia beating.
In DNAI1-mutated HAECs’ axoneme, ultrastructure analysis by
TEM showed that ODA were absent or shorter than in normal
HAECs (Figure 5B-B). TEM on axonemes of DNAI1-treated cells
were analyzed and some cilia had normal amounts of ODA, while
in other cilia the ODA were partially absent (Figure 5B-C and 5B-
Figure 2. Lentiviral vectors containing DNAI1 cDNA sequence
with or without HA tag. (A) pK-DNAI1 and pK+DNAI1 were derived
from pGFP, with DNAI1 cDNA sequence in place of eGFP gene. pK-DNAI1
contains an intact DNAI1 cDNA sequence associated with a modified
Kozak sequence (atccccaccauga), whereas pK+DNAI1 contains an intact
Kozak sequence associated with a modified DNAI1 cDNA sequence
(c.4A.G; p.I2V). (B) HA tag addition at 39 side of DNAI1 cDNA sequence
in pK-DNAI1 and pK+DNAI1 vectors forms pK-HA and pK+HA vectors,
respectively. Striped box: site of sequence modification; filled box: HA
tag sequence. Empty boxes located 59 and 39 to cDNA sequence
represent 59 and 39 LTR (Long Terminal Repeat), respectively.
doi:10.1371/journal.pgen.1000422.g002
Figure 3. HA-tagged DNAI1 gene transcription analysis by RT–
PCR, in transduced normal HAECs. RT products were obtained
using non-ciliated (NC) or re-ciliated (RC) HAECs mRNA and DNAI1 (P5)
or HA-tag (HA) specific primers. All PCR products were obtained using
DNAI1 cDNA specific primers. (1–3) Non-infected cells: (1) NC HAECs and
P5 primer, (2) RC HAECs and P5 primer, (3) RC HAECs and HA primer; (4–
6) Infected cells with HA-tagged DNAI1 and RT with HA primer: RC
HAECs infected with (4) pK-HA or (5) pK+HA, (6) NC HAECs infected with
pK-HA; (7–9) PCR control templates (no RT) were (7) genomic DNA, (8)
pK-HA vector, (9) no DNA; (10) 100 bp DNA ladder. The symbol ‘‘-’’
means no infection by viral particles.
doi:10.1371/journal.pgen.1000422.g003
Figure 4. DNAI1 protein detection with the use of DNAI1 anti-
dyn69 antibody. Western blot analysis of proteins lysates from
transfected 293Bosc cells with (1) pK-DNAI1, (2) pK+DNAI1, (3) pK-HA, (5)
pK+HA, vectors; (4) control of transfection.
doi:10.1371/journal.pgen.1000422.g004
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pGFP infected DNAI1-mutated HAECs. ODA increased signifi-
cantly to 5.6761.83 (p,0.0001) and 5.7362.10 (p,0.002) in
DNAI1-mutated HAECs treated with pK-DNAI1 and pK-HA,
respectively. By contrast, there was no significant difference
between DNAI1-mutated HAECs treated by pK-DNAI1 or pK-
HA. The distribution of the number of ODA per axoneme
presented a single peak in pGFP infected DNAI1-mutated HAECs
but two peaks in pK-DNAI1 and pK-HA treated cells (Figure 6).
IDA analysis showed no difference between control and DNAI1-
treated cells (data not shown).
Discussion
In the present study, we demonstrated that a SIV-based vector
pseudotyped with VSV-G protein, previously described to
efficiently transduce human dendritic cells [25,26], could also
efficiently infect normal cultured HAECs [27]. Previous studies
showed that Murine Leukemia virus (MuLV) [28] and Feline
Immunodeficiency Virus pseudotyped with VSV-G envelope [29]
could transduce HAECs in culture. Though, this transduction was
only possible from the basolateral surface of polarized HAECs. We
did not know whether a Simian Immunodeficiency Virus would
transduce although we could foresee that transduction would be
more efficient from the basolateral surface of HAECs since it was
pseudotyped with VSV-G. We did not know also whether de-
differentiated cells would be transduced. It appeared that whatever
the conditions used in this study, a certain proportion of cultured
HAECs were infected. We then selected the conditions that
seemed to provide the higher percentage of infected cells in
culture. In any case, these conditions are strikingly different from
in vivo situation where HAECs are a component of a complex
epithelium recovered by a thin layer of mucus. Moreover,
Polybrene which seemed to improve viral infection in cultured
cells cannot be used in vivo due to side-effects. In a next step, we
demonstrated transcription and translation of the transduced
DNAI1 cDNA. Finally, we showed that DNAI1-mutated HAECs
treated by DNAI1 gene transfer recovered ciliary beating whereas
GFP-treated cells’ cilia remained immotile, thus supporting our
concept that PCD gene therapy was possible using DNAI1 gene.
This conceptual proof is essential in the perspective of a human
gene therapy.
Since it was impossible to obtain a vector containing a
conserved Kozak sequence associated with a normal DNAI1
cDNA sequence, we decided to construct two vectors: one with a
modified Kozak sequence upstream a conserved DNAI1 cDNA
sequence (pK-DNAI1), and another one with a conserved Kozak
Figure 5. Images of transduced DNAI1–mutated HAECs and electron microscopic sections of cilia. (A) At J’+31, vesicles had cells with cilia
transduced with either pGFP (A-A) or pK-DNAI1 vectors (A-C). However, cilia of cells transduced with pGFP were immotile whereas cells transduced
with pK-DNAI1 vectors were beating. Figures (A-B) and (A-D) represent the variations of the video signal during the time of recording (400 msec) along
a virtual line delimited by the ‘‘.’’ and ‘‘,’’ signs on figures (A-A) and (A-C), respectively. The periodic beat of cilia is clearly visible on figure (A-D)
compared to the immotility of cilia on figure (A-B). Black bar on figure (A-A): 10 mm. Black bar on figure (A-D): 100 msec. DNAI1–mutated HAECs
transduced with pK-HA vector containing HA-tagged DNAI1 cDNA sequence gave identical results (data not shown). See Video S1 and Video S2. (B)
Axoneme ultrastructural analysis by TEM (A-D): (B-A) Normal HAEC. (B-B) DNAI1–mutated HAEC treated with pGFP. (B-C) DNAI1–mutated HAEC treated
with pK-DNAI1 vector. (B-D) DNAI1–mutated HAEC treated with pK-HA vector. Arrowheads indicate ODA. Axoneme diameter is about 0.2 mm.
doi:10.1371/journal.pgen.1000422.g005
Figure 6. Distribution of the number of ODA per axoneme in
DNAI1–mutated infected HAECs. X axis, number of ODA per
axoneme; Y axis, percentage of axonemes with a given number of
ODA. Empty bars, DNAI1–mutated HAECs infected with pGFP; filled bars,
cells infected with pK–DNAI1; striped bars, cells infected with pK-HA.
doi:10.1371/journal.pgen.1000422.g006
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(pK+DNAI1). However, both vectors turned out to be equally
efficient in terms of transcription and translation. Moreover, the
addition of a HA tag at the 39 end did not alter the transcription
neither the translation of both vectors. Consequently, we pursued
the infection experiments on DNAI1-mutated HAECs with the
Kozak modified/DNAI1 conserved pair of vectors (with and
without HA tag).
We were unable to detect endogenous DNAI1 protein and
DNAI1 HA-tagged protein on Western blot of cultured normal
HAECs presumably because the amount of extracted proteins
from cultured HAECs was too low. However, translation from the
various vectors was confirmed in transfected 293Bosc cells.
We also failed to label HA-tagged DNAI1 protein in the cilia of
infected HAECs. However, the observation of the rescue of ciliary
beating after DNAI1 treatment of DNAI1-mutated HAECs with
either one of the selected vectors supported the idea that normal
DNAI1 proteins, HA-tagged or not, were efficiently localized to
cilia. This functional evidence was reinforced by ultrastructural
analysis showing an increased number of ODA in axonemes with
tagged and untagged DNAI1 proteins. Beside these observations,
no difference in the number of IDA was detected between control
and DNAI1-treated HAECs, in agreement with the knowledge that
DNAI1 proteins specifically belong to ODA.
In DNAI1-mutated HAECs treated by DNAI1, a partially
uncoordinated ciliary beating was observed, probably because as
we demonstrated in early experiments, about half of infected cells
were not transduced. As a consequence, HAECs aggregates are
mosaics composed of cells with immotile cilia and other cells with
beating cilia. The number of ODA per axoneme in treated DNAI1-
mutated HAECs is lower than normal because these values reflected
a mix population of HAECs: efficiently transduced cells and
untransduced cells, as shown in the bimodal distribution of ODA
per axoneme in Figure 6. In this respect, our results are consistent
with the recessiveinheritance type of PCD disease for which a normal
copy of the DNAI1 gene is sufficient to an absence of symptoms.
In order to improve the number of rescued HAECs, we need to
improve transduction efficiency, but respiratory epithelium is not
exclusively composed of ciliated cells and at least seven other cell
types are present [30]. To produce viral particles which would
preferentially target human airway ciliated cells, the VSV-G large
cell tropism protein could be replaced by another envelope protein
from one of the various viruses known to infect airway epithelium,
ie. coronavirus or Influenza virus [31,32]. Influenza virus
receptors, as a2,3-linked sialic acid receptors, were described to
be specifically localized on ciliated airway and type II alveolar
epithelial cells in both mouse and human respiratory epithelium,
and on a subpopulation of basal cells in humans [32]. By contrast,
a2,6-linked sialic acid receptors are expressed on human ciliated
and goblet cells but not in the mouse. Therefore, it should be
interesting to evaluate on our current culture model, the use of
hemagglutinin (HA) from selected Influenza viruses which
preferentially bind to ciliated cells. Finally, Szecsi et al. demon-
strated that HA envelope protein of H7N1 and H5N1 avian
viruses was successfully associated with retroviral-based vectors
resulting in higher titres of infected cells than with VSV-G [33].
Airway ciliated cells are differentiated cells which do not
proliferate and their cycle life span is supposed to be relatively
short. In the mouse model, ciliated cells renewal was reported to
be provided by Clara cells which are also essential in the alveolar
type II cells generation [34]. Nevertheless, Park et al. reported that
after an injury event, murine ciliated epithelial cells could
transdifferentiate into other cell types and restored the airway
epithelium [35]. In the human airway epithelium, Hajj et al.
demonstrated that basal cells were able to regenerate as well as to
differentiate into secretory and ciliated cells [36]. Targeting these
basal cells with a lentiviral vector would result in the stable
integration of the therapeutic gene with no need to repeat
infections. The specificity of cells’ targeting has been recently
improved by taking into account the presence of proteases at the
cell surface [37]. Thus, cell transduction can be achieved only in
cell types that have the capacity to bind viral surface glycoprotein
and to cleave the protease substrate because the surface
glycoprotein of several enveloped viruses are expressed as
precursor proteins that need to be cleaved into two subunits by
cellular proteases to promote cell entry.
Finally, DNAI1 gene transfer could be applied to other genes
causing PCD, as DNAH5 mutations are responsible for at least
28% of PCD cases [21]. However, another vector should be
considered for this gene because of size limitation of lentivirus. As
an alternative, AAV vectors offer a good safety profile in particular
because viral DNA does not integrate into the genome of
transfected cells. However, AAV repeated administration triggers
anti-viral immune response and its packaging capacity is too
limited to hold the DNAH5 gene (13.9 kb). High-capacity episomal
vectors offer the possibility to deliver not only a large gene but also
the whole genomic locus including regulatory regions which
ensures a physiological expression with tissue and time specificity.
However, delivery of extrachromosomal DNA with non viral or
viral strategies is so far limited to cell lines. This system, tough, is
appropriate for long-term treatment as in PCD because chromo-
some-based episomal systems contain elements enabling the cell to
process episome as an additional chromosome with a mitotic
stability .99% in cell lines [38].
Material and Methods
Patient Data
The diagnosis of a male patient affected by PCD was based on
clinical signs (recurrent upper and lower respiratory tract
infections since early in life, nasal polyps and complete situs
inversus – Kartagener syndrome). In addition, he was sterile.
Electron microscopy of the cilia showed no ODA. Ex vivo culture
of epithelial airway cells according to Jorissen’s method demon-
strated that his cilia were 6 mm-long and totally immotile. Analysis
of his DNA demonstrated that he harbored heterozygous
compound DNAI1 mutations: c.48+2_48+3insT and c.1543G.A
[20]. This patient signed an informed consent allowing us to
experiment on nasal biopsies which consisted in removing the
most anterior part of his middle nasal turbinate on both side. This
study complies with the rules of the local ethical committee.
Human Airway Epithelial Cell Culture
Human airway epithelial cells (HAECs) from normal subjects
were obtained from nasal turbinates which were removed and
discarded in the process giving access to the ethmoidal sinus.
Patients were operated for tumours located in the ethmoidal
region and had no respiratory disease.
Cells from control subjects and the patient were grown using the
immerged cell culture previously described by Jorissen et al. [27].
Briefly, ciliated cellswereisolatedandcultured thedayfollowingthe
biopsy (J+1) in collagen-coated flasks to de-differentiate in non-
ciliated cells. When they reached 80–90% confluence, collagen was
digested (J’, 7–10 days post-seeding) and cells were suspended in
flasks with rotation to re-differentiate in the form of ciliated vesicles.
Cells were infected at J+1o rJ +3. Non-ciliated cells were
harvested at J+7 to 10 (J’) and re-ciliated cells were fully re-
differentiated at J’+28.
Ciliary Beating Recovery
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To generate DNAI1 cDNA (AF091619), we extracted total RNA
from ciliated HAEC and synthesized the cDNA. A pair of primers
was designed to amplify the full-length cDNA. Six supplementary
sets of specific primers were used to sequence DNAI1 cDNA. The
full-length DNAI1 cDNA PCR product was cloned.
Addition of enzyme restriction sites in 59 and 39 DNAI1 cDNA
sequence was performed using two sets of primers. The
BAMHIDNAI1_for and NCOIDNAI1_for primers (forward)
added BamH I and Nco I restriction sites upstream DNAI1 cDNA
sequence, respectively. The XHOIDNAI1_rev primer (reverse)
added a Xho I restriction site downstream DNAI1 cDNA sequence.
Addition of hemagglutinin (HA) tag downstream DNAI1 cDNA
sequence was performed by PCR using lentiviral vectors
containing DNAI1 cDNA (pK+DNAI1 or pK-DNAI1) as template
and upDNAI1_for (forward)/lowHA_rev (reverse) primers. For
more information see Text S1.
Lentiviral Vectors
The lentiviral vector system used in this study was derived from
SIV vectors described by Negre et al. [25,26]. Five different
lentiviral vector constructs were used all under the transcriptional
control of the human Elongation Factor-1 promoter (EFS): (1)
pR4SA-EFS-GFP-W (pGFP), (2) pK-DNAI1, (3) pK+DNAI1, (4)
pK-HA, (5) pK+HA. The pGFP vector contains the eGFP cDNA
sequence. The pK-DNAI1 and pK+DNAI1 vector constructs are
essentially the same as the pGFP vector but with the DNAI1 cDNA
sequence replacing the eGFP gene sequence, using BamHI / Xho I
and Nco I/Xho I sites, respectively (Figure 2A). The pK-DNAI1
vector has a modified Kozak sequence with an intact DNAI1
cDNA sequence whereas pK+DNAI1 has an intact Kozak
sequence with a modification at position 4 of the DNAI1 cDNA
sequence, resulting in DNAI1 second amino acid modification:
isoleucine.valine. The pK-HA and pK+HA vector constructs
correspond to pK-DNAI1 and pK+DNAI1 vectors, respectively,
with a 39 DNAI1 cDNA hemagglutinin (HA) tag addition, using Blp
I/Xho I restriction sites (Figure 2B).
Lentiviral Transduction
Three sets of experiments were carried out.
In the first set, normal HAECs were transduced the day of
seeding (J+1) on collagen-coated flasks or at J+3, and the cells were
incubated for 24 hours with the lentivirus at MOI (Multiplicity Of
Infection) of 7, 35 and 75 in the presence or absence of 6 mg/mL
Polybrene (1,5-dimethyl-1,5-diazaundecamethylene polymetho-
bromide, hexadimethrine bromide). MOI is the ratio of infectious
agents (e. g. lentivirus) to infection targets (e. g. cells). Then,
medium was completely changed in order to remove debris and
inactive lentiviruses. Two days post-infection, reporter gene
expression was analyzed by FACS.
In the second set of experiments, normal HAECs were
transduced or not the day of seeding (J+1) at MOI75 with
Polybrene with pK-HA or pK+HA. RNA was extracted before or
after re-ciliation.
In the third set of experiments, transduction was performed on
DNAI1-mutated HAECs at J+1, at MOI 75, with the use of
Polybrene and cells were cultured to generate ciliated vesicles.
RT–PCR Analysis
Tagged DNAI1 gene expression was revealed by reverse
transcription PCR (RT-PCR) on infected HAEC. Non-ciliated
cells were collected the day of collagen digestion (J’) and ciliated
cells were collected when they were fully covered by cilia (J’+28).
Poly(A)
+ mRNA was isolated by the Dynabeads Oligo(dT)25
purification kit, according to the manufacturer’s protocol (Dynal
Biotech, Norway).
Western Blotting Analysis
Transient transfection of 293Bosc cells was performed with each
four different plasmids: pK-DNAI1,p K +DNAI1, pK-HA or
pK+HA. Western blot analysis was carried out according to
standard techniques (Text S1).
Video Analysis and Ciliary Beat Frequency (CBF)
In order to assess the functional activity of the ciliated DNAI1-
mutated cells after lentiviral transduction, video recordings were
performed with a 640 objective lens in the light path at different
steps of the culture in flasks, by using an Olympus IX50 inverted
phase-contrast microscope. The control eGFP fluorescence was
observed with a magnifying digital camera SCION CFW 1308M
(Scion Corporation, Frederick, MD) and the recovery of ciliary
beating was recorded with high speed digital video camera
pco.1200 hs (PCO, Germany). The digital image-sampling rate
was software-controllable using CamWare and for all experiments
the sampling rate was set at 500 frames per second (fps).
For measurements of ciliary beat frequency (CBF), the video
images of active ciliated cells were captured with a 6100 oil-
immerged objective lens, using Leica DMRXA microscope and
pco.1200 hs camera. A time-motion representation was obtained
and analyzed using ImageJ software (National Institutes of Health,
USA). Briefly, a line cutting cilia close to their tip was drawn. The
‘‘reslice’’ function of ImageJ was then used to obtain the video
signal along this line (y axis) during 400 msec (x axis). Finally, the
data were expressed as mean6SD from at least three regions of
interest. Values for normal HAECs were used as controls.
Transmission Electron Microscopy (TEM) and Statistical
Analysis
Transmission electron microscopic analyses were processed on
ciliated vesicles obtained after HAECs culture, as described by
Jorissen et al. [27]. Amounts of ODA were expressed as mean6SD
from n axonemes (n=17 for pGFP, n=21 for pK-DNAI1,n=1 1
for pK-HA). Values of HAEC infected with pGFP, pK-DNAI1 or
pK-HA were statistically analysed by Student t test and the
significance was calculated for a two-tailed test.
See Text S1 for more details.
Supporting Information
Text S1 Supporting Material and Methods.
Found at: doi:10.1371/journal.pgen.1000422.s001 (0.10 MB PDF)
Figure S1 HA-tagged DNAI1 expression in 293Bosc cell line
transfected with pK-HA vector. (A) Nuclei were labelled with
DAPI (blue) and image was superimposed with transmission
image. (B) HA tag was immunostained using anti-HA antibody
associated with biotinylated goat anti-mouse and FITC-conjugat-
ed ExtrAvidin (green). A specific cytoplasmic localization was
observed. Scale bars, 10 mm.
Found at: doi:10.1371/journal.pgen.1000422.s002 (2.21 MB TIF)
Figure S2 DNAI1-mutated HAEC transduced with pGFP
vector. eGFP fluorescence superimposed with transmission image.
(A) At J+3, HAEC are de-differentiated and adherent (bar,
50 mm). (B) At J’+17, HAEC are re-differentiated and in
suspension as ciliated vesicles. Arrowheads indicate cilia (bar,
20 mm).
Found at: doi:10.1371/journal.pgen.1000422.s003 (2.54 MB TIF)
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transduced with GFP. DNAI1-mutated Human Airway Epithelial
Cells were transduced with a GFP containing lentiviral vector.
Cilia are completely immotile as in non-transduced cells of this
patient. The video was recorded at 500 frames per second. This
video includes 201 frames.
Found at: doi:10.1371/journal.pgen.1000422.s004 (7.23 MB AVI)
Video S2 DNAI1-mutated Human Airway Epithelial Cells after
transduction with DNAI1 lentiviral vectors. DNAI1-mutated
Human Airway Epithelial Cells were transduced with a pK-
DNAI1 and pK-HA lentiviral vectors. In both cases, beating cilia
were clearly visible as on this video from pK-DNAI1 treated cells.
The video was recorded at 500 frames per second. This video
includes 200 frames.
Found at: doi:10.1371/journal.pgen.1000422.s005 (7.19 MB AVI)
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